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Abstract: Community-acquired pneumonia (CAP) is a common disease responsible for significant
morbidity and mortality. However, the definite etiology of CAP often remains unresolved, suggesting
that unknown agents of pneumonia remain to be identified. The recently discovered members of
the order Chlamydiales, Chlamydia-related bacteria (CRB), are considered as possible emerging
agents of CAP. Parachlamydia acanthamoebae is the most studied candidate. It survives and replicates
inside free-living amoeba, which it might potentially use as a vehicle to infect animals and humans.
A Mycoplasma pneumoniae outbreak was observed in Kymenlaakso region in Southeastern Finland
during August 2017–January 2018. We determined the occurrence of Chlamydiales bacteria and
their natural host, free-living amoeba in respiratory specimens collected during this outbreak
with molecular methods. Altogether, 22/278 (7.9%) of the samples contained Chlamydiales DNA.
By sequence analysis, majority of the CRBs detected were members of the Parachlamydiaceae family.
Amoebal DNA was not detected within the sample material. Our study further proposes that
Parachlamydiaceae could be a potential agent causing atypical CAP in children and adolescents.
Keywords: Chlamydia-related bacteria; Parachlamydia acanthamoebae; Chlamydia pneumoniae; pneumonia;
respiratory tract infections; disease outbreak; nucleic acid amplification test
1. Introduction
Community-acquired pneumonia (CAP) is a common disease responsible for significant morbidity
and mortality. A variety of micro-organisms, including bacteria and viruses, can cause CAP. The most
common bacterial pathogen in typical (sudden-onset) CAP is Streptococcus pneumoniae. The more
slowly developing atypical CAP presenting often with extrapulmonary symptoms can be caused
by Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, or viruses. Despite recent
advances in microbiological techniques, the definite etiology of CAP often remains unresolved.
Chlamydia pneumoniae belongs to the Chlamydiaceae family within the order Chlamydiales, a group
of obligate intracellular bacteria featuring a biphasic developmental cycle. Chlamydiaceae contains
also well-known veterinary pathogens Chlamydia psittaci and Chlamydia pecorum that are known to be
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zoonotically transmitted to humans from infected animals (birds and livestock, respectively) and can
cause pneumonia. In addition to Chlamydiaceae, the order Chlamydiales contains a wide and evolving
set of novel bacteria, recently suggested to be taxonomically classified in 13 additional families within
the order and collectively called Chlamydia-related bacteria (CRB) [1]. Many of the Chlamydia-related
bacteria naturally reside in free-living amoeba, and CRB have been detected in a wide variety of
environmental samples such as water and soil [2], but also in a wide range of animals, insects and
arthropods [3]. Several of the CRBs have been suggested to cause respiratory disease and pneumonia
in humans. The role of Parachlamydia acanthamoebae as an agent of pneumonia is most studied and
many of the modified Koch’s postulates are fulfilled. For instance, the pathogenicity is suggested by
sero-epidemiological and molecular studies as well as by an experimental pneumonia model including
a treatment trial [4,5]. Waddlia chondrophila is mainly associated with tubal factor infertility [6] and
adverse pregnancy outcome [7], but also with lower respiratory tract infections [4,8,9]. In some
reports, Simkania negevensis and Rhabdochlamydia spp. are detected in association with respiratory
infections [10–12]. In our previous study, Rhabdochlamydia spp. DNA was detected in 12% of respiratory
specimens from Finnish patients with respiratory tract infection [11].
A M. pneumoniae outbreak was observed in Kymenlaakso region in Southeastern Finland during
August 2017–January 2018 [13]. The aim of this study was to study occurrence of Chlamydiales
bacteria in respiratory specimens collected during this outbreak with molecular methods targeting the
Chlamydia-related bacteria and their natural host, free-living amoeba.
2. Materials and Methods
2.1. Respiratory Tract Samples
The respiratory swab samples analysed in this study were collected during a M. pneumoniae
outbreak observed in Kymenlaakso region in Southeastern Finland during August 2017–January 2018
(as described in detail in [13]). Respiratory tract swab specimens were available from two groups,
from a total of 278 individuals. The first group contained 96 individuals who sought publicly funded
healthcare consultation at local GPs or hospitals in the Kymenlaakso region and who were subsequently
tested for M. pneumoniae nucleic acid between 1 August 2017 and 31 January 2018. The second
group contained 182 individuals who participated in school screening arranged in four schools in
the same area (Virolahti Middle School, Virojoki School, Virolahti High Shool and Klamila School,
in Kymenlaakso region, Southeastern Finland). To collect information on their symptoms, individuals
in the second group were asked to fill in a questionnaire. According to the survey, 112 had respiratory
symptoms and/or fever, 15 did not report such symptoms, and from 55 individuals the information
was not available.
2.2. DNA Extraction
DNA was extracted from respiratory specimens using MagNA Pure LC Total Nucleic Acid
Isolation Kit (Roche Diagnostics GmbH, Mannheim, Germany). In detail, 300 µL of specimen was lysed
with 300 µL of MagNA Pure Lysis/Binding Buffer (Roche Diagnostics GmbH, Mannheim, Germany).
Five hundred µL (MagNA Pure LC) of specimen lysate was extracted with the MagNA Pure LC and
eluted in 50 µL of the elution buffer.
2.3. Detection of Chlamydia pneumoniae
A multiplex real-time PCR assay for simultaneous detection ofM.pneumoniae,Chlamydia pneumoniae
and mutations associated with macrolide resistance in Mycoplasma pneumoniae 23S rRNA gene along
with an internal control developed by us [14] was used (Table 1). This assay amplifies C. pneumoniae
ompA gene [15], and the analytical sensitivity (limit of detection with 95% probability) was 0.13 IFU/PCR
reaction [14].
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2.4. PanChlamydiales-PCR
Specimens were screened with a Chlamydiales-specific amplification method (PanChlamydiales-
PCR) as described earlier by Lienard et al. 2011 [16], with slight modifications [17] (Table 1.). This PCR
method amplifies a ∼200-bp fragment of the 16S rRNA gene and has been shown to detect a wide
range (at least all 15 chlamydial reference strains tested) of different members of the Chlamydiales order.
A PCR mixture of 25 µL contained 12.5 µL Maxima Probe/ROX qPCR master mix (2X) (Thermo Fisher
Scientific, Waltham, MA, USA), 100 nM primers panCh-Fwd and panCh-Rev, and 100 nM panCh-Probe
(Table 1). The primers and probe were purchased from Integrated DNA Technologies. Amplification
was performed with a 7500 Real Time PCR system (Applied Biosystems, Foster City, CA, USA Negative
(water as extraction control and PCR reaction without template) and positive (DNA extracted from
Simkania negevensis VR-1471) controls were included in each amplification run.
Extreme precautions were taken to avoid contamination in PCR. DNA extraction and preparation
of PCR reaction mixes were conducted in separate laboratories with separate equipment, dedicated
to pre-PCR activities only. In each run, 2 wells of PCR mix only were included as negative controls
and 8 wells were used as nucleic acid extraction negative controls. Cycling conditions were 10 min
at 95 ◦C, followed by 45 cycles of 15 s at 95 ◦C and 60 s at 60 ◦C, all carried out in an Applied
Biosystems® 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). All samples
were tested in duplicate. Amplicons were sequenced. Samples with Ct ≤ 37 or with Ct 37–40 and
a Chlamydiales family levels sequence (> 90% similarity with established Chlamydiales sequence [18])
were considered positive.
Table 1. Primers and probes used in this study.
Target Primer/Probe Sequence Reference
M. pneumoniae
Hypothetical protein
C985_0367
MP Fw ATGTACTATCAGCAAAAGCTCAGTATGG [14]
MP Rev CCACATACCGCTTTAAGTTAGCAA
MP probe Cy5-CTAACCAAAACAGCCCTTCAACGGCA-Iowa blackRQ-Sp
C. pneumoniae ompA
CP Fw AAGGGCTATAAAGGCGTTGCT [14,15]
CP Rev TGGTCGCAGACTTTGTTCCA
CP probe Tx Red-TCCCCTTGCCAACAGACGCTGG-Iowa black RQ-Sp
Homo sapiens
beta-globin chain
BG Fw GGTTGGGATAAGGCTGGATTATT [14]
BG Rev CAGGAGCTGTGGGAGGAAGA
BG Probe JOE/ZEN-CAAGCTAGGCCCTTTTGCTAATCATGTTCA-Iowablack FQ
M. pneumoniae gene
for 23S rRNA
MR–MP Fw GCTATAGACTCGGTGAAATCCAGG [14]
MR–MP Rev GCTACAGTAAAGCTTCACTGGGTC
MR–MP SimpleProbe® GCGCA XI ACGGGACGGAAAGAC
Chlamydiales 16S
rRNA gene
panCh-Fwd CCGCCAACACTGGGACT * [16,17]
panCh-Rev GGAGTTAGCCGGTGCTTCTTTAC
panCh-Probe FAM-CTACGGGAGGCTGCAGTCGAGAATC-BHQ1
Acanthamoeba spp.
18S rRNA gene
Acan Fw CCAGATCGTTTACCGTGAA * [19]
Acan Rv TATTAATGCCCCCAACTATCC
Acan probe FAM-TCTGCCACCGAATACATTAGCATGG-Iowa black FQ
Vahlkampfiidae spp.
18S rRNA gene
Vahl Fw GTATAGTCGCAAGACCGAAAC * [20]
Vahl Rv CAAGACAGATCACTCCACGA
Vahl probe Cy5-GGGAAACTCACCAGGTCAGGACAC-Iowa black FQ
Vermamoeba vermiformis
18S rRNA gene
Verm Fw TACGAGGTCAGGACACTGTG * [21]
Verm Rv ACCATCCGGAGTTCTCG
Verm probe JOE-AATTCCTAGTAGGCGCGAGTCATCAA-Iowa black FQ
* Modified after.
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2.5. Amoeba PCR
All samples giving a signal in PanChlamydiales-PCR were studied further by PCR methods
targeting free-living amoeba, the natural hosts of CRB. The primers and probes used for amoeba
detection are presented in Table 1 [19–21]. The PCR reactions (total volume 25 µL) contained 12.5 µL
Maxima Probe/ROX qPCR Master Mix (2X) (Thermo Scientific, Waltham, MA, USA), and 5 µL template
DNA. For Acanthamoeba and Vahlkampfiidae (including Naegleria spp.), a duplex PCR reaction,
500 nM of primers and 250 nM probe were used. For Vermamoeba PCR reaction, 200 nM of both primers
and probe were used. PCR was performed with 7500 Real-Time PCR system (Applied Biosystems).
The cycling conditions were 95 ◦C for 10 min and 45 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min.
2.6. Sequencing and Phylogeny
The pan-Chlamydiales qPCR amplicons were purified by using an Illustra ExoProStar 1-Step kit
(GE Healthcare, Buckinghamshire, United Kingdom) according to the manufacturer’s instructions.
Both the forward and reverse strands of the PCR products were sequenced by using primers panFseq
and panRseq [16] in the sequencing unit of the Institute for Molecular Medicine Finland. Sequences
were compared to the known sequences in the NCBI database by BLAST analysis. For family level
classification, the first established CRB strain of the BLAST hit list was determined, and if the sequence
identity was ≥90%, the two sequences were considered as members of the same CRB family [17,18,22].
The Verrucomicrobium spinosum sequence was included as an outgroup (GenBank accession number
X90515), as it was used previously as an outgroup for all Chlamydiales [23]. We constructed a Bayesian
posterior-probability consensus tree using a total chain length of 1,100,000 and a burn-in length of
11,000. The analysis was carried out by using Geneious software [24]. Sequences were aligned by
using the MUSCLE plug-in [25], and Bayesian analysis was done with the MrBayes plug-in [26].
3. Results
3.1. Detection of Chlamydia pneumoniae
All samples were studied by a PCR based method amplifying Mycoplasma pneumoniae and
Chlamydia pneumoniae [14]. Of the 278 samples, only one (1/278, 0.4%) was shown to contain
Chlamydia pneumoniae DNA. This sample was from a patient in group 1 (who sought health care
consultation with signs and symptoms suggestive of M. pneumoniae infection) (sample ID 1410, Table 2).
Table 2. Samples containing Chlamydiales DNA.
Sample
ID
Age
(Years) Gender GROUP * School ** Symptoms Chlamydiales Family Other
1410 8 male 1 yes Chlamydiaceae C. pneumoniae PCR+
1563 10 female 1 yes Parachlamydiaceae M. pneumoniae PCR+, IgM+
1385 6 male 1 yes Parachlamydiaceae
1463 7 female 1 yes Parachlamydiaceae M. pneumoniae IgM+
1510 7 male 1 yes Parachlamydiaceae
V15 13 female 2 1 NA Parachlamydiaceae
V45 14 female 2 1 yes fever, cough, rhinitis Parachlamydiaceae
V8 13 male 2 1 NA Parachlamydiaceae M. pneumoniae PCR+
V48 14 female 2 1 yes fever, cough, rhinitis Parachlamydiaceae
V57 14 male 2 1 NA Parachlamydiaceae
V62 9 male 2 2 yes cough, rhinitis Parachlamydiaceae
V71 9 male 2 2 no Parachlamydiaceae
V104 12 male 2 2 yes cough, rhinitis Parachlamydiaceae
V111 17 female 2 3 yes fever, cough, rhinitis Parachlamydiaceae
V114 14 female 2 1 NA Parachlamydiaceae
K4 9 female 2 4 yes fever, cough Parachlamydiaceae
V230 17 female 2 3 NA Parachlamydiaceae
V74 9 male 2 2 yes fever Criblamydiaceae
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Table 2. Cont.
Sample
ID
Age
(Years) Gender GROUP * School ** Symptoms Chlamydiales Family Other
K13 10 male 2 4 yes fever, cough, rhinitis Criblamydiaceae
V211 11 female 2 2 yes rhinitis Simkaniaceae
V42 14 female 2 1 yes cough, rhinitis Unclassified
V49 14 male 2 1 yes fever Unclassified
* 1 = Sought healthcare, 2 = Screening in schools. ** 1 = Virolahti Middle School, 2 = Virojoki School, 3 = Virolahti
High Shool, 4 = Klamila School.
3.2. Detection of Chlamydiales DNA
Altogether 22/278 (7.9%) samples gave a positive result by PanChlamydiales PCR. Of these
22 samples, 5 were from symptomatic individuals that belonged to the group 1 (sought health care
consultation). Of the 17 Chlamydiales DNA-positive samples in group 2 (school screening), 11 were
from individuals with respiratory symptoms (rhinitis and/or cough and/or fever) and one from those
without such symptoms (9.8% and 6.7%, respectively). However, the interpretation is limited by
the small number of those reporting no symptoms (n = 15). No information on possible respiratory
symptoms or fever was available from five individuals with Chlamydiales DNA.
As expected, the specimen positive for C. pneumoniae DNA (ID 1410, group 1) was amplified also
by PanChlamydiales primers and was included in the set of 22 positive specimens. Of these 22 samples,
only two contained also M. pneumoniae DNA (sample no V8, group 2 and 1563, group 1). In addition,
one individual had serological evidence of a recent M. pneumoniae infection (ID 1463, group 1) (Table 2).
3.3. Amoeba PCR
Amoebal DNA (Acanthamoeba, Vahlkampfiidae, including Naegleria, or Vermamoeba) was not
detected in any of the PanChlamydiales-positive samples (0/22).
3.4. Sequencing and Phylogeny
By sequence analysis, 16 (72.7%) of the 22 samples containing Chlamydiales DNA were classified
as members of the family Parachlamydiaceae. By this method, sequences belonging to Criblamydiaceae
family were identified in two (9.1%) and to Simkaniaceae family in one (4.5%) of the 22 respiratory
samples. One sample contained a sequence (4.4%) that was classified as C. pneumoniae: by BLAST
analysis, the DNA sequence of the PanChlamydiales-PCR amplicon showed 99% identity with the
Chlamydia pneumoniae genome assembly YK41, GenBank no LN849050. The same sample was identified
as positive by the Chlamydia pneumoniae-specific PCR. In two (9.1%) samples, the DNA sequences were
shown to belong to Chlamydiales order, but remained unclassified on family level.
In the phylogenetic tree, theC. pneumoniae sequence grouped together with the reference sequences
from the Chlamydiaceae family. Interestingly, the two unclassified Chlamydiales sequences (V49 and
V42) grouped together in the phylogenetic tree, and formed a cluster separate from the Chlamydiaceae
family (Figure 1). This might indicate a previously undescribed Chlamydiales bacteria, although
the support for this clade is rather low (72%). The two individuals were both from the same school
(Virolahti Middle School) and same class (a 14-year old male and a 14-year old female). The boy was
reported to have fever and the girl had cough and rhinitis. Some other sequences, such as K4 and
V111 may also be examples of novel species, with high support for the clade (94%). The C. pneumoniae
specific-PCR did not amplify these specimens, although the internal control was amplified.
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Figure 1. Bayesian posterior probability tree of the sequences in this study along with reference
sequences and Verrucomicrobium spinosum as an outgroup to root the tree. Some clades are well
resolved whereas some are weakly, probably due to short sequence length. The scale bar represents 2%
genetic divergence.
4. Discussion
Starting in 2017, an increasing incidence of respiratory infections, including pneumonias,
were observed among school-children and their family members in Kymenlaakso re ion in Southeastern
Finland. Testing of respiratory swab and serum samples from 327 individuals by a PCR method [14]
and serology, respectively, provided evidence of Mycoplas a pneumoniae infection in 19% f the
school-children and their family members [13]. To further investigate the cluster of respiratory
infections, respiratory tract swabs from 96 of these individuals (mainly from children) and additional
182 swabs collected from children attending schools i the area were amplified by Chlamy iales-PCR.
With the PanChlamydiales-PCR assay [16], we detected Chlamydiales DNA in 22 respiratory
samples. By subsequent sequence analysis, only one was shown to belong to the Chlamydiaceae family,
and it was further classified as C. pneumoniae, an established cause of respiratory infections, including
atypical pneumonia. The sequencing result was consistent with the C. pneumoniae-positive PCR data
strengthe ing the plausibility of the results obtai ed with PanC lamydiales-PCR and sequencing.
Among specimens collected during this outbreak, neither Chlamydia psittaci nor Chlamydia caviae,
which recently have been reported to cause pneumonia in humans, i.e., due to exposure to ill guinea
pigs, were seen [27–29]. Interestingly, however, two of the sequences that, by the scheme used,
remaine as “unclassified”, bunched together in the phylogenetic analysis (sequences V42 an V49;
Figure 1) and might represent a novel type of Chlamydia-related bacteria. Both samples were from
symptomatic 14-year-old individuals, class mates (male an female) from the same school.
Parachlamydia acanthamoebae is the most studied member of the chlamydia-related bacteria, including
several studies presenting evidence supporting its role as a CAP causing pathogen [4,5,30,31]. In vitro,
Parachlamydia is indeed able to enter and grow in cells present in respiratory tract, macrophages [32] and
pneumocytes [33]. Majority of the chlamydiales seq ences within our respiratory tract specimens (73%)
were taxonomically classified as members of the Parachlamydiaceae family, which is in concordance
with earlier studies. Casson et al. set up a real-time PCR method specific forParachlamydia acanthamoebae,
and as they applied it to 39 nasopharyngeal aspirates obtained from children with respiratory syncytial
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virus-negative bronchiolitis, they found 13/39 to contain P. acanthamoebae DNA [34]. However, only one
of their results could be confirmed by sequencing. Lienard et al. used the PanChlamydiales PCR and
subsequent sequence analysis and detected Parachlamydiaceae DNA in 26/422 (6.2%) nasopharyngeal
swab samples taken from hospitalized children (between 1–15 years old) [16]. This is in good agreement
with our data, as in our study the prevalence of parachlamydiaceae DNA was 5.8 % among respiratory
specimens collected from patients between 6–17 years old. In our study 63% of the samples containing
Parachlamydiaceae DNA were from individuals with respiratory symptoms and/or fever. In the study
by Lienard et al., Parachlamydiaceae DNA was more often detected among patients without (60%) than
with (40%) pneumonia [16]. However, as their group without pneumonia were hospitalized children,
they supposedly were not completely asymptomatic. In contrast to these data, among 564 adult patients
(median age of 76 years; range 21–101 years) with moderately severe community-acquired pneumonia,
oropharyngeal samples were studied again by the PanChlamydiales PCR method, and only one was
found to contain Chlamydiales DNA [35,36]. Similarly, in our earlier study on respiratory samples
from patients sent for C. pneumoniae and M. pneumoniae nucleic acid testing, P. acanthamoebae DNA
was not detected (n = 102) [11]. However, Rhabdochlamydia spp. DNA was detected in 16/136 (12%)
of samples studied. The median age of these Rhabdochlamydia spp. positive patients was 52 (range
11–72). Thus, the results may reflect a difference among the study populations (adults vs. adolescents),
or endemic/epidemic outbreak(s) of different members of Chlamydiales order.
There are no general treatment recommendations for conditions associated with P. acanthamoeabae.
The antimicrobial susceptibility of Parachlamydiaceae, tested in amoebae, was similar to that of other
Chlamydiales, and treatment with macrolides was recommended for parachlamydial pneumonia [37].
As macrolides are also included in the treatment options of pneumonia due toM. pneumoniae, most likely
also the individuals with P. acanthamoebae and other Chlamydiales bacteria benefitted from such therapy.
Even today in as many as 50% of the cases the microbe causing pneumonia remains unidentified.
For example, as pointed out by Polkinghorne et al. [27], there is an increasing number of reports on
CAP cases caused by bacteria belonging in the genus Chlamydia that thus far have been considered
solely animal pathogens, i.e., Chlamydia caviae. In addition to members of chlamydiaceae, a wide range
of the newly detected chlamydia-related bacteria have been associated with respiratory symptoms
including pneumonia. This study further confirms that Parachlamydiaceae can be included in the list
of potential agents causing atypical CAP in children and adolescents.
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